comparemela.com

Latest Breaking News On - Life science advisors - Page 4 : comparemela.com

Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies.

United-kingdom
London
City-of
Sylvia-wheeler
David-cory
Sarah-mathieson
Eiger-biopharmaceuticals-inc
Nasdaq
Corporate-affairs
International-liver-congress
Eiger-biopharmaceuticals
European-association

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

/PRNewswire/ Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an.

Japan
Osaka
United-states
Canada
Sylvia-wheeler
David-cory
Sarah-mathieson
Anges-clinical-research-laboratories
Nasdaq
Prnewswire-eiger-biopharmaceuticals-inc
European-medicines-agency
Eiger-biopharmaceuticals-inc

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

PALO ALTO, Calif. and OSAKA, Japan, May 10, 2022 /PRNewswire/ Eiger Biopharmaceuticals Inc. and AnGes Inc. today announced that the companies entered into an agreement for the regulatory.

Japan
Osaka
United-states
Canada
Sylvia-wheeler
David-cory
Sarah-mathieson
Anges-clinical-research-laboratories
Nasdaq
Prnewswire-eiger-biopharmaceuticals-inc
European-medicines-agency
Eiger-biopharmaceuticals-inc

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

/PRNewswire/ Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an.

Japan
Osaka
United-states
Canada
Sylvia-wheeler
David-cory
Sarah-mathieson
Anges-clinical-research-laboratories
Nasdaq
Prnewswire-eiger-biopharmaceuticals-inc
European-medicines-agency
Eiger-biopharmaceuticals-inc

Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies.

Sylvia-wheeler
Sarah-mathieson
Prnewswire-eiger-biopharmaceuticals-inc
Eiger-biopharmaceuticals-inc
Compensation-committee-of-eiger-board-directors
Corporate-affairs
Nasdaq
Compensation-committee
Eiger-biopharmaceuticals
Nasdaq-listing-rule
Life-science-advisors

vimarsana © 2020. All Rights Reserved.